NEW YORK, Feb. 8, 2024 /PRNewswire/ — The intrauterine contraceptive devices (IUD) market is estimated to grow by USD 965.49 million from 2023 to 2027 at a CAGR of 3.98% according to Technavio. AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE…